The cobas s 201 system is a complete nucleic acid testing (NAT) solution able to meet both current and future needs of blood screening labs.
It provides blood screening labs the confidence and efficiency of extensively proven real-time PCR technology, highly reliable and robust modular automation, convenient ready-to-use reagents, and future menu expansion on the same validated system. Future assay developments will utilize multi-channel capabilities, providing real-time discrimination of major viruses. The system is backed by world-class service and strong local support.
Customer benefits
Easy sample preparation with large load capacity
The cobas s 201 system automates every step of the real-time PCR-based blood screening process, and includes automated pooling using the Hamilton® STAR instrument1.
Ensured result integrity
Closed-tube format require no user interaction after sample loading is completed, thus reducing the risk of sample contamination and optimizing workflow.
Fast procedure, fast results, higher throughput
Real-time PCR allows amplification and detection of RNA and DNA within hours.
cobas TaqScreen MPX Test
Single qualitative in vitro multiplex test covering HBV, HCV, HIV-1 groups M and O and HIV-2, that is highly sensitive for mini-pool testing.
Scalable, modular system
The flexible, mix-and-match scalability of the cobas s 201 system helps your NAT lab work more efficiently. The system streamlines your workflow, supports simultaneous multiple assay processing, and accommodates integrated backup to maximize lab productivity.
Powerful Pooling and Data Management (PDM)
The PDM software and server provides built-in redundancy, full system audit and data security, and supports various pool sizes or individual donation testing. It supports simultaneous pool creation to handle multiple assays and provides multiple search and reporting options.
* Not available in the EU
1 Hamilton is a registered trademark of Hamilton Company, Reno, Nevada/USA.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.
Roche Molecular Diagnostics operates in the U.S. as the legal entity Roche Molecular Systems, Inc.
Visitor Insights Survey
Welcome to Roche Molecular Diagnostics
Whether you are a first-time visitor or a frequent visitor, we would appreciate your opinion to help improve our Web site.
Would you be willing to answer a brief questionnaire? It will take less than 5 minutes.
YesNo, thanks
This questionnaire is voluntary and your use of this Web site is not conditional upon your participation.
The questionnaire does not include any health-related questions, it strictly focuses on Web-related topics.
In accordance to Roche's privacy policy, your
responses will be treated with the strictest of confidence and not passed on to any third parties for their marketing purposes.
